Atlas Trials

A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection

Clinical trial NCT01220947 · COMPLETED

Trial details

NCT number
NCT01220947
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2010-11-01
Primary completion
2012-12-01
Enrollment
421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.